Relaunching hemoglobin-based oxygen carriers for human and veterinary use.
Industry: Health Care
Latest Trade: ()
First Day Return:
Return from IPO:
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 04/26/2022 |
Offer Price | |
Price Range n/a | |
Offer Shares (mm) | n/a |
Deal Size ($mm) | $30 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | |
Offer Price | |
Price Range n/a | |
Offer Shares (mm) | n/a |
Deal Size ($mm) | $30 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
Underwriters |
---|
WestPark Capital |
Company Data | |
---|---|
Headquarters | Souderton, PA, United States |
Founded | 1984 |
Employees at IPO | 10 |
Website www.hbo2therapeutics.com |